2025
Associations of Pre-diagnostic Serum Liver Enzyme Levels with Lung Cancer Risk in Predominantly Low-income African and European Americans
Xu S, Cai H, Wu J, Shi J, Courtney R, Yoon H, Shu X, Blot W, Zheng W, Cai Q. Associations of Pre-diagnostic Serum Liver Enzyme Levels with Lung Cancer Risk in Predominantly Low-income African and European Americans. Carcinogenesis 2025, bgaf052. PMID: 40879454, DOI: 10.1093/carcin/bgaf052.Peer-Reviewed Original ResearchLC riskOdds ratioSouthern Community Cohort StudyIncident LC casesAfrican AmericansConfidence intervalsCommunity Cohort StudyLung cancer riskSerum ALT levelsPotential effect modifiersConditional logistic regressionLiver enzyme levelsEuropean AmericansMatched ControlsALT levelsCancer riskInverse associationLow-incomeEffect modifiersStudy participantsBaseline serum alanine aminotransferaseBaseline serum alkaline phosphataseLowest tertileMedian follow-up timeCohort study
2011
Ostα depletion protects liver from oral bile acid load
Soroka CJ, Velazquez H, Mennone A, Ballatori N, Boyer JL. Ostα depletion protects liver from oral bile acid load. AJP Gastrointestinal And Liver Physiology 2011, 301: g574-g579. PMID: 21719738, PMCID: PMC3174539, DOI: 10.1152/ajpgi.00141.2011.Peer-Reviewed Original ResearchConceptsExcess bile acidsCholic acid feedingWild-type miceBile acid overloadBile acidsLiver injuryAcid overloadLower serum ALT levelsIntestinal bile acid absorptionAcid feedingBile acid loadSerum ALT levelsBile acid absorptionBile acid lossBile duct ligationEffective therapeutic targetBile acid homeostasisWild-type controlsALT levelsUrinary eliminationIntestinal lossObstructive cholestasisIntestinal functionDuct ligationUrinary clearance
1999
A prospective, community‐based evaluation of liver enzymes in individuals with hepatitis C after drug use
Inglesby T, Rai R, Astemborski J, Gruskin L, Nelson K, Vlahov D, Thomas D. A prospective, community‐based evaluation of liver enzymes in individuals with hepatitis C after drug use. Hepatology 1999, 29: 590-596. PMID: 9918940, DOI: 10.1002/hep.510290219.Peer-Reviewed Original ResearchConceptsSerum ALT levelsALT levelsALT valuesDrug usePrior illicit drug useSerum alanine transaminase levelsAlanine transaminase levelsNormal ALT valuesHepatitis C virusIllicit drug useImportant disease outcomesElevated ALTHepatitis CTransaminase levelsInitial visitLiver biopsyVisit variabilityC virusCommunity-based evaluationLiver enzymesDisease outcomeHCVPatientsMore visitsNatural history
1996
Effect of Human Immunodeficiency Virus on Hepatitis C Virus Infection among Injecting Drug Users
Thomas D, Shih J, Alter H, Vlahov D, Cohn S, Hoover D, Cheung L, Nelson K. Effect of Human Immunodeficiency Virus on Hepatitis C Virus Infection among Injecting Drug Users. The Journal Of Infectious Diseases 1996, 174: 690-695. PMID: 8843204, DOI: 10.1093/infdis/174.4.690.Peer-Reviewed Original ResearchConceptsSerum HCV RNA concentrationHepatitis C virus infectionC virus infectionHCV RNA concentrationHIV infectionVirus infectionAlanine aminotransferaseDrug usersHuman immunodeficiency virus (HIV) immunosuppressionCD4 cells/HIV-negative patientsHIV-positive IDUsStage of HIVCD4 lymphocyte countHCV RNA levelsSerum ALT levelsHIV-negative participantsHuman immunodeficiency virusInjecting Drug UsersRNA concentrationSemiannual visitsALT levelsHCV infectionHIV RNAHIV seroconversion
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply